LUND, SWEDEN / ACCESSWIRE / February 23, 2022 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F)
Spago Nanomedical’s annual report for 2021 is from at this time out there on the firm’s web site, www.spagonanomedical.se.
For additional data, please contact Mats Hansen, CEO Spago Nanomedical AB, +46 46 811 88, [email protected].
Spago Nanomedical AB is a Swedish nanomedicines firm in medical growth section. The corporate´s growth tasks are primarily based on a platform of polymeric supplies with distinctive properties for extra exact analysis and therapy of strong tumors. Spago Nanomedical´s share is listed on Nasdaq First North Progress Market (ticker: SPAGO). For additional data, see www.spagonanomedical.se.
FNCA Sweden AB is the Licensed Adviser of the corporate, +46 8 528 00 399, [email protected].
Attachments
Annual report 2021
SOURCE: Spago Nanomedical
View supply model on accesswire.com:
https://www.accesswire.com/690011/Spago-Nanomedical-Publishes-the-Annual-Report-for-2021
